Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics
Revance Therapeutics, Inc. (RVNC)
Today's Latest Price: $24.72 USD
0.62 (-2.45%)
Updated Jul 10 4:00pm
Add RVNC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
RVNC Stock Summary
- With a price/sales ratio of 7,307.39, Revance Therapeutics Inc has a higher such ratio than 99.77% of stocks in our set.
- With a year-over-year growth in debt of 533.83%, Revance Therapeutics Inc's debt growth rate surpasses 96.8% of about US stocks.
- Revenue growth over the past 12 months for Revance Therapeutics Inc comes in at -94.94%, a number that bests only 0.86% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Revance Therapeutics Inc, a group of peers worth examining would be VNRX, TRVN, AUPH, PSTI, and CNCE.
- RVNC's SEC filings can be seen here. And to visit Revance Therapeutics Inc's official web site, go to www.revance.com.
RVNC Daily Price Range
RVNC 52-Week Price Range
RVNC Stock Price Chart Technical Analysis Charts
RVNC Price/Volume Stats
| Current price | $24.72 | 52-week high | $27.97 |
| Prev. close | $25.34 | 52-week low | $9.88 |
| Day low | $24.42 | Volume | 653,791 |
| Day high | $25.74 | Avg. volume | 777,637 |
| 50-day MA | $22.06 | Dividend yield | N/A |
| 200-day MA | $18.75 | Market Cap | 1.41B |
Revance Therapeutics, Inc. (RVNC) Company Bio
Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company was founded in 1999 and is based in Newark, California.
Loading social stream, please wait...